Elligo Health Research Stock
Elligo Health Research brings clinical research to physician practices and accelerate the development of medical device and therapies.
Sign up today and learn more about Elligo Health Research Stock
Invest in or value your shares in one or many pre-IPO companies through an EquityZen investment vehicle.
About Elligo Health Research Stock
Elligo Health Research is a healthcare company that revolutionizes the clinical research industry with a novel approach to common trial challenges including patient participation and enrollment, and physician participation. They provide physicians and their patients the opportunity to participate in clinical trials using advanced health care informatics. Improved access to physicians and patients means sponsors reach trial enrollment goals faster, and new products are accelerated to market, benefiting patients everywhere. It brings clinical research to physician practices, accelerating the development of pharmaceutical, biotechnology, and medical device products and therapies. Elligo Health Research was founded in 2016 and is headquartered in Austin, Texas.
Funding History
March 2018 | $16.0M |
---|---|
May 2019 | $20.0M |
September 2021 | $135M |
Management
CEO
John Potthoff
President
Chad Moore
CIO & CTO
Jacylyn Bodmer
CFO
Karen Flaherty
COO
Eli Alford
Chief Legal Officer
Amy Staedtler
Board Observer
Nathan Cohen
Chief Data Officer
Michael Ibara
Board Director
Steven Skolsky
Board Observer
Gary Abrahams
Executive Vice President, Research Operations
Juliet Moritz
Director, Healthcare Partnerships
Doug Olsen
Press
businesswire - Apr, 8 2024
Elligo Health Research Expands EU and U.K. Clinical Trial Support With WHYZE Healthpharmiweb - Feb, 20 2024
Elligo Health Research Expands EU and U.K. Clinical Trial...businesswire - Feb, 11 2024
Elligo Health Research Announces Expansion of Study Marketplace With Syneos Healthbusinesswire - Feb, 11 2024
Elligo and Avallano Launching Patient-First, AI-Powered Clinical Trials Ecosystem